NCT07128966View on ClinicalTrials.gov

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

Not yet recruitingOBSERVATIONAL

Enrollment

100,000

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2035

Study Completion Date

September 1, 2036

Conditions

HealthyLupusCeliacKidney DiseaseChronicDermatologic

Interventions

OTHER

Observation

This is non-interventional, observational only

Trial Locations (1)

02420

Joined Bio, Lexington

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Joined Bio

INDUSTRY